These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 35720402)

  • 1. Chimeric Antigen Receptor (CAR) Regulatory T-Cells in Solid Organ Transplantation.
    Gille I; Claas FHJ; Haasnoot GW; Heemskerk MHM; Heidt S
    Front Immunol; 2022; 13():874157. PubMed ID: 35720402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of a Chimeric Antigen Receptor Specific for Donor HLA Class I Enhances the Potency of Human Regulatory T Cells in Preventing Human Skin Transplant Rejection.
    Boardman DA; Philippeos C; Fruhwirth GO; Ibrahim MA; Hannen RF; Cooper D; Marelli-Berg FM; Watt FM; Lechler RI; Maher J; Smyth LA; Lombardi G
    Am J Transplant; 2017 Apr; 17(4):931-943. PubMed ID: 28027623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precision Engineering of an Anti-HLA-A2 Chimeric Antigen Receptor in Regulatory T Cells for Transplant Immune Tolerance.
    Muller YD; Ferreira LMR; Ronin E; Ho P; Nguyen V; Faleo G; Zhou Y; Lee K; Leung KK; Skartsis N; Kaul AM; Mulder A; Claas FHJ; Wells JA; Bluestone JA; Tang Q
    Front Immunol; 2021; 12():686439. PubMed ID: 34616392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-HLA-A2-CAR Tregs prolong vascularized mouse heterotopic heart allograft survival.
    Wagner JC; Ronin E; Ho P; Peng Y; Tang Q
    Am J Transplant; 2022 Sep; 22(9):2237-2245. PubMed ID: 35434896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of Allograft Rejection by Use of Regulatory T Cells With an MHC-Specific Chimeric Antigen Receptor.
    Noyan F; Zimmermann K; Hardtke-Wolenski M; Knoefel A; Schulde E; Geffers R; Hust M; Huehn J; Galla M; Morgan M; Jokuszies A; Manns MP; Jaeckel E
    Am J Transplant; 2017 Apr; 17(4):917-930. PubMed ID: 27997080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human CD8+ Tregs expressing a MHC-specific CAR display enhanced suppression of human skin rejection and GVHD in NSG mice.
    Bézie S; Charreau B; Vimond N; Lasselin J; Gérard N; Nerrière-Daguin V; Bellier-Waast F; Duteille F; Anegon I; Guillonneau C
    Blood Adv; 2019 Nov; 3(22):3522-3538. PubMed ID: 31730699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic testing and specificity mapping of alloantigen-specific chimeric antigen receptors in regulatory T cells.
    Dawson NA; Lamarche C; Hoeppli RE; Bergqvist P; Fung VC; McIver E; Huang Q; Gillies J; Speck M; Orban PC; Bush JW; Mojibian M; Levings MK
    JCI Insight; 2019 Mar; 4(6):. PubMed ID: 30753169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor.
    MacDonald KG; Hoeppli RE; Huang Q; Gillies J; Luciani DS; Orban PC; Broady R; Levings MK
    J Clin Invest; 2016 Apr; 126(4):1413-24. PubMed ID: 26999600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Building a CAR-Treg: Going from the basic to the luxury model.
    Rosado-Sánchez I; Levings MK
    Cell Immunol; 2020 Dec; 358():104220. PubMed ID: 33096321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CAR-Tregs as a Strategy for Inducing Graft Tolerance.
    Wagner JC; Tang Q
    Curr Transplant Rep; 2020 Sep; 7(3):205-214. PubMed ID: 33816057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor-specific chimeric antigen receptor Tregs limit rejection in naive but not sensitized allograft recipients.
    Sicard A; Lamarche C; Speck M; Wong M; Rosado-Sánchez I; Blois M; Glaichenhaus N; Mojibian M; Levings MK
    Am J Transplant; 2020 Jun; 20(6):1562-1573. PubMed ID: 31957209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD39 delineates chimeric antigen receptor regulatory T cell subsets with distinct cytotoxic & regulatory functions against human islets.
    Wu X; Chen PI; Whitener RL; MacDougall MS; Coykendall VMN; Yan H; Kim YB; Harper W; Pathak S; Iliopoulou BP; Hestor A; Saunders DC; Spears E; Sévigny J; Maahs DM; Basina M; Sharp SA; Gloyn AL; Powers AC; Kim SK; Jensen KP; Meyer EH
    Front Immunol; 2024; 15():1415102. PubMed ID: 39007132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell therapy in transplantation: A comprehensive review of the current applications of cell therapy in transplant patients with the focus on Tregs, CAR Tregs, and Mesenchymal stem cells.
    Mansourabadi AH; Mohamed Khosroshahi L; Noorbakhsh F; Amirzargar A
    Int Immunopharmacol; 2021 Aug; 97():107669. PubMed ID: 33965760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimeric Antigen Receptor (CAR) Treg: A Promising Approach to Inducing Immunological Tolerance.
    Zhang Q; Lu W; Liang CL; Chen Y; Liu H; Qiu F; Dai Z
    Front Immunol; 2018; 9():2359. PubMed ID: 30369931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overcoming barriers to widespread use of CAR-Treg therapy in organ transplant recipients.
    Cremoni M; Massa F; Sicard A
    HLA; 2022 Jun; 99(6):565-572. PubMed ID: 35233971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supraphysiological FOXP3 expression in human CAR-Tregs results in improved stability, efficacy, and safety of CAR-Treg products for clinical application.
    Henschel P; Landwehr-Kenzel S; Engels N; Schienke A; Kremer J; Riet T; Redel N; Iordanidis K; Saetzler V; John K; Heider M; Hardtke-Wolenski M; Wedemeyer H; Jaeckel E; Noyan F
    J Autoimmun; 2023 Jul; 138():103057. PubMed ID: 37224732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Next Frontier of Regulatory T Cells: Promising Immunotherapy for Autoimmune Diseases and Organ Transplantations.
    Terry LV; Oo YH
    Front Immunol; 2020; 11():565518. PubMed ID: 33072105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Driving allotolerance: CAR-expressing Tregs for tolerance induction in organ and stem cell transplantation.
    Edinger M
    J Clin Invest; 2016 Apr; 126(4):1248-50. PubMed ID: 26999608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tregs integrate native and CAR-mediated costimulatory signals for control of allograft rejection.
    Rosado-Sánchez I; Haque M; Salim K; Speck M; Fung VC; Boardman DA; Mojibian M; Raimondi G; Levings MK
    JCI Insight; 2023 Oct; 8(19):. PubMed ID: 37669115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chimeric antigen receptor T
    Eskandari SK; Daccache A; Azzi JR
    Trends Immunol; 2024 Jan; 45(1):48-61. PubMed ID: 38123369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.